Similar articles

• Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.

  Ledermann JA. Ledermann JA. Eur J Cancer. 1994;30A(5):574-6. doi: 10.1016/0959-8049(94)90519-3. Eur J Cancer. 1994. PMID: 8080666 Review. No abstract available.
• Serum tumour markers in lung cancer.

  Hansen M. Hansen M. Scand J Clin Lab Invest Suppl. 1991;206:93-101. doi: 10.3109/00365519109107730. Scand J Clin Lab Invest Suppl. 1991. PMID: 1658919 Review. No abstract available.
• Tumour marker evaluation in patients with lung cancer.

  Seregni E, Botti C, Bogni A, Bombardieri E. Seregni E, et al. Scand J Clin Lab Invest Suppl. 1995;221:67-71. doi: 10.3109/00365519509090567. Scand J Clin Lab Invest Suppl. 1995. PMID: 7652492 No abstract available.
• Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung.

  Güner G, Oktay G, Akkoçlu A, Karlikaya C. Güner G, et al. Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):306S. doi: 10.1042/bst021306s. Biochem Soc Trans. 1993. PMID: 8224452 No abstract available.
• [The prescription of serum tumor markers in a general hospital].

  Watine J, Charet JC, Augé MC. Watine J, et al. Presse Med. 1998 May 16;27(18):862, 864. Presse Med. 1998. PMID: 9767874 French. No abstract available.